Interleukin-6 Knockout Reverses Macrophage Differentiation Imbalance and Alleviates Cardiac Dysfunction in Aging Mice.

Yuan Wang,Shan Zhu,Wen Wei,Yi Tu,Chuang Chen,Junlong Song,Juanjuan Li,Changhua Wang,Zhiliang Xu,Shengrong Sun
DOI: https://doi.org/10.18632/aging.103749
2020-01-01
Aging
Abstract:Several interleukins (ILs) have been shown to be involved in aging, but the effects of IL-6 on aging-related cardiac dysfunction remain unknown. In this study, the expression and sources of cardiac IL-6 in aging hearts were investigated for the first time. The results showed that cardiac IL-6 expression in mice gradually increased with age, and the expression at 16 months, 20 months and 25 months was higher than that at 3 months. In addition, cardiac macrophages (Mempty sets) were shown to be the main sources of IL-6 in aging mice. IL-6 knockout (KO) significantly alleviated cardiac dysfunction, increased M2 macrophage (Mempty set2) differentiation, reduced M1 macrophage (Mempty set1) differentiation and protected against cardiomyocyte apoptosis in aging mice. IL-6 KO also reversed the stimulatory effect of doxorubicin (DOX) treatment on Mempty set1s and the inhibitory effect of DOX treatment on Mempty set2s in vitro. Furthermore, the mRNA expression of both aging markers and apoptosis-related markers was markedly inhibited by IL-6 KO. Our results suggest that aging can be significantly reversed by IL-6 KO and that the mechanisms of this effect are related to alleviation of Mempty set1/Mempty set2 imbalance and protection against apoptosis in cardiomyocytes.
What problem does this paper attempt to address?